- 學位論文
Leptin、 Ghrelin 、Glutathione以及oxidation 在於第二型糖尿病人與正常人兩者血液間之比較
Comparison between type 2 diabetes and normal persons on leptin, ghrelin, glutathione and oxidation
摘要
因此本實驗收集了40位第二型糖尿患者及15位正常人血液樣本，利用商業檢驗套組來分析，以比較第二型糖尿病人與正常人兩者血液間之Leptin、Ghrelin、 麩胱苷肽(Glutathione； GSH)濃度，以及oxidation情形。 本實驗結果為：在第二型糖尿病女性病人其Leptin濃度比男性病人高亦比正常女性Leptin濃度高，都有統計學上的顯著差異(P<0.05)；在Ghrelin濃度則是男性糖尿病人Ghrelin濃度較正常人高，女性糖尿病人Ghrelin濃度比正常人較低，不論男女糖尿病人與正常人相比皆無統計學上的顯著差異(P<0.05)；男性糖尿病人GSH濃度比正常人高，並且兩者相比有統計學上的顯著差異(P<0.05)；另外糖尿病人不論男女其MDA值及HbA1c濃度皆比正常人高，並且有統計學上的顯著差異(P<0.05)。顯示出糖尿病人確實比正常人有較高的氧化及醣化傷害壓力存在著，因此在減緩糖尿病相關心血管併發症的發生是值得注意的。
並列摘要
Diabetes is one of the major chronic diseases in Taiwan. The impact of leptin and ghrelin upon diabetic progression has been paid attention. This study included 40 type II diabetic patients and 15 healthy controls. Blood levels of leptin, ghrelin, GSH and lipid oxidation were analyzed. Results showed that diabetic female had significantly higher leptin than diabetic male (P<0.05), diabetic male had significantly higher ghrelin than diabetic female (P<0.05). Diabetic patients has greater level of GSH than healthy control (P<0.05). Both oxidation level, determined as MDA, and HbAlc level were significantly greater in diabetic patients (P<0.05). These results indicated that the influence of leptin, ghrelin and HbAlc in diabetic patients needs to be paid more attention.
參考文獻
延伸閱讀
- 楊雅雰（2015）。以質譜法分析(一)在糖尿病患者與大腸癌患者的血紅蛋白上的氯化、硝化與氧化修飾; (二)在大腸癌患者的血紅蛋白上的穀胱甘肽修飾〔碩士論文，國立中正大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0033-2110201614034990
- Chu, P. C. (2015). 以非目標性代謝體方法學搜尋與第二型糖尿病發生風險相關之血清代謝產物 [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2015.02036
- 朱映諭（2010）。高效能液相層析法對人體血清中di(2-ethylhexyl) phthalate 及mono(2-ethylhexyl) phthalate之同時分析研究〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-2407201023172600
- Li, L. C., Chu, C., Huang, C. N., Kornelius, E., Lo, S. C., & Yang, Y. S. (2022). Glycemic Lowering Effectiveness of Linagliptin/Metformin in Type 2 Diabetes by Age, Body Mass Index, and Renal Function. Formosan Journal of Endocrinology and Metabolism, 13(2), 74-82. https://doi.org/10.6856/FJEM.202212_13(2).0010
- Li, L. C., Chu, C., Huang, C. N., Kornelius, E., Lo, S. C., & Yang, Y. S. (2020). Glycemic Lowering Effectiveness of Linagliptin/Metformin in Type 2 Diabetes by Age, Body Mass Index, and Renal Function. Formosan Journal of Endocrinology and Metabolism, (), 1-9. https://doi.org/10.6856/FJEM.202212/PP.0002